Free Trial
NYSE:BVS

Bioventus (BVS) Stock Price, News & Analysis

Bioventus logo
$7.64 +0.56 (+7.91%)
Closing price 04:00 PM Eastern
Extended Trading
$7.64 0.00 (-0.07%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Bioventus Stock (NYSE:BVS)

Key Stats

Today's Range
$7.08
$7.74
50-Day Range
$6.14
$7.53
52-Week Range
$5.81
$14.38
Volume
603,873 shs
Average Volume
399,140 shs
Market Capitalization
$631.67 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$13.75
Consensus Rating
Moderate Buy

Company Overview

Receive BVS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bioventus and its competitors with MarketBeat's FREE daily newsletter.

BVS Stock News Headlines

"I'm risking my reputation on this"
A massive supply shock is building in the crypto market that could send Bitcoin to $300,000 this year. That's why we've rushed to update our book "Crypto Revolution" – to show you exactly how to position yourself for this historic opportunity.tc pixel
Brokers Set Expectations for Bioventus FY2025 Earnings
Bioventus Inc. (BVS) Q2 2025 Earnings Call Transcript
Bioventus Inc. Reports Q2 2025 Financial Results
See More Headlines

BVS Stock Analysis - Frequently Asked Questions

Bioventus' stock was trading at $10.50 at the start of the year. Since then, BVS stock has decreased by 27.2% and is now trading at $7.64.

Bioventus Inc. (NYSE:BVS) released its earnings results on Tuesday, November, 5th. The company reported $0.06 EPS for the quarter, hitting the consensus estimate of $0.06. The firm had revenue of $138.96 million for the quarter, compared to analysts' expectations of $132.57 million. Bioventus had a negative net margin of 7.11% and a positive trailing twelve-month return on equity of 15.61%.

Bioventus (BVS) raised $126 million in an initial public offering on Thursday, February 11th 2021. The company issued 7,400,000 shares at $16.00-$18.00 per share. Morgan Stanley, J.P. Morgan, Goldman Sachs and Canaccord Genuity acted as the underwriters for the IPO.

Top institutional investors of Bioventus include Nantahala Capital Management LLC (6.43%), American Century Companies Inc. (1.37%), Divisadero Street Capital Management LP (1.32%) and Geode Capital Management LLC (1.28%). Insiders that own company stock include John A Bartholdson, Juniper Investment Company, Ll, Mark Leonard Singleton, William A Hawkins, Anthony P Bihl III, Anthony D'adamio, John Nosenzo, Robert E Claypoole, Katrina J Church and Kenneth Michael Reali.
View institutional ownership trends
.

Shares of BVS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Bioventus investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), Advanced Micro Devices (AMD), ServiceNow (NOW), Adobe (ADBE) and Arista Networks (ANET).

Company Calendar

Last Earnings
11/05/2024
Today
8/22/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Medical Equipment
Current Symbol
NYSE:BVS
CIK
1665988
Fax
N/A
Employees
1,200
Year Founded
N/A

Price Target and Rating

High Price Target
$15.00
Low Price Target
$12.00
Potential Upside/Downside
+94.2%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.75
Research Coverage
4 Analysts

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
17.27
P/E Growth
N/A
Net Income
-$156.23 million
Net Margins
-7.11%
Pretax Margin
-10.41%
Return on Equity
15.61%
Return on Assets
4.01%

Debt

Debt-to-Equity Ratio
1.85
Current Ratio
1.41
Quick Ratio
0.99

Sales & Book Value

Annual Sales
$564.14 million
Price / Sales
1.04
Cash Flow
$0.56 per share
Price / Cash Flow
12.58
Book Value
$2.80 per share
Price / Book
2.53

Miscellaneous

Outstanding Shares
82,679,000
Free Float
54,455,000
Market Cap
$585.37 million
Optionable
Not Optionable
Beta
0.83
Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NYSE:BVS) was last updated on 8/22/2025 by MarketBeat.com Staff
From Our Partners